시장보고서

상품코드

1629319

흡입 캡슐 시장 : 제제별, 용도별, 방출 메커니즘별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Inhalation Capsules Market, By Formulation, By Application, By Release Mechanism, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 12월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 288 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

흡입 캡슐 시장 규모는 2023년 8억 3,190만 달러로 2024년부터 2032년까지 CAGR 6.50%로 확대될 것으로 예상됩니다.

흡입 캡슐 시장 - 시장 역학

호흡기질환의 유병률 증가로 시장 수요 촉진

호흡기질환의 유병률 증가는 의약품 시장에서 흡입 캡슐에 대한 수요를 촉진하는 중요한 요인입니다. 천식, 만성폐쇄성폐질환(COPD), 기타 폐 관련 질환과 같은 호흡기질환은 대기오염, 흡연, 고령화, 유전적 소인과 같은 요인으로 인해 더욱 흔해지고 있습니다. 이러한 질환은 장기적인 관리가 필요한 경우가 많으며, 흡입 요법은 가장 효과적인 치료법 중 하나로 간주되어 신속하고 표적화된 완화를 제공하는 것으로 알려져 있습니다.

호흡기질환이 증가함에 따라 보다 효과적이고 간편한 치료법에 대한 요구도 증가하고 있습니다. 정확한 용량과 효율적인 약물전달을 통해 폐에 직접 약물을 전달하는 흡입 캡슐은 천식이나 COPD와 같은 질환을 앓고 있는 환자들에게 선호되는 선택이 되고 있습니다. 이 캡슐은 폐에서 약물의 흡수를 개선하고, 치료 결과를 개선하며, 경구 치료에서 나타나는 전신 부작용의 빈도를 감소시킬 수 있습니다. 세계보건기구(WHO)에 따르면, COPD는 2030년까지 세계 3위의 사망 원인이 될 것으로 예상됩니다. 이러한 COPD 환자의 증가는 천식 유병률의 증가와 함께 효과적인 흡입 요법에 대한 수요를 불러일으키고 있습니다. 그 결과, 제약사들이 이러한 광범위한 호흡기질환에 대처할 수 있는 혁신적인 솔루션을 지속적으로 개발함에 따라 흡입 캡슐 시장은 큰 성장을 이룰 것으로 예상됩니다.

흡입 캡슐 시장 - 주요 인사이트

당사의 연구 분석가들이 공유한 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 매년 약 6.50%의 CAGR로 성장할 것으로 예상됩니다.
제형 세분화를 기반으로, 분말 흡입 캡슐은 2023년에 가장 큰 시장 점유율을 보일 것으로 예상됐습니다.
용도별로는 천식이 2023년 주요 부문으로 꼽혔습니다.
지역별로는 북미가 2023년 주요 수익원이 되었습니다.

흡입 캡슐 시장 - 세분화 분석:

흡입 캡슐 세계 시장은 제형, 용도, 방출 메커니즘, 지역에 따라 세분화됩니다.

시장은 제형별로 분말 흡입 캡슐, 액체 충전 캡슐로 분류됩니다. 분말 흡입 캡슐은 몇 가지 중요한 요인으로 인해 시장을 독점하고 있습니다. 첫째, 천식이나 COPD와 같은 증상에서 가장 필요한 폐에 약물을 효율적으로 전달할 수 있습니다. 미세분말은 폐 깊숙이 침투하여 약효를 극대화합니다.

시장은 용도별로 천식, 만성폐쇄성폐질환, 폐감염증, 폐고혈압으로 분류됩니다. 천식은 높은 유병률, 환경적 요인, 현재 진행 중인 치료의 발전으로 인해 예측 기간 동안 천식이 시장을 독점하고 있으며, 그 우위를 유지할 가능성이 높습니다. 전 세계적으로 2억 6,000만 명 이상이 천식을 앓고 있으며, 가장 흔한 만성 호흡기질환 중 하나입니다. 이러한 환자 수는 흡입제를 포함한 천식 치료제에 대한 지속적인 수요를 촉진하고 있습니다.

흡입 캡슐 시장 - 지리적 인사이트

흡입 캡슐 시장은 호흡기질환의 유병률 증가와 첨단 약물전달 시스템의 채택 증가로 인해 다양한 지역에서 성장하고 있습니다. 북미는 잘 구축된 의료 인프라, 높은 의료비, 천식 및 COPD와 같은 호흡기질환 환자 인구가 많기 때문에 큰 점유율을 차지하고 있습니다. 유럽 또한 고령화 인구의 증가와 강력한 의료 시스템이 흡입 요법의 채택을 뒷받침하고 있어 중요한 역할을 하고 있습니다. 아시아태평양은 호흡기질환 발병률 증가, 의료 인프라 확대, 의료 접근성 향상을 위한 정부의 노력에 힘입어 시장이 빠르게 성장할 것으로 예상됩니다. 라틴아메리카는 흡연율 증가, 도시화, 대기 오염으로 인해 수요가 증가하고 있으며, 중동 및 아프리카는 호흡기질환의 부담이 증가하고 있지만 고급 의료 서비스에 대한 접근성이 제한되어 있습니다. 그러나 이들 지역에서는 의료서비스가 개선되고 있어 향후 시장 성장의 원동력이 될 것으로 예상됩니다.

흡입 캡슐 시장 - 경쟁 상황:

흡입 캡슐 시장은 효과적인 호흡기 치료에 대한 수요 증가와 약물전달 기술의 지속적인 발전으로 인해 경쟁이 치열해지고 있습니다. 각 업체들은 혁신적인 흡입 제품, 특히 생체이용률을 높이고 약효 발현을 가속화할 수 있는 개선된 제형의 건조 분말 흡입기(DPI) 개발에 주력하고 있습니다. 제약사, 연구기관, 의료 서비스 제공자 간의 전략적 파트너십과 협업은 시장 도달 범위를 넓히고 제품 제공을 강화하는 데 매우 중요합니다. 또한, 시장 경쟁력을 유지하고 제품의 가용성을 유지하기 위해서는 규제 준수와 다양한 지역 보건 당국의 승인을 확보하는 것이 필수적이며, 이는 시장 성장을 더욱 촉진하고 있습니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제11장 주요 벤더 분석 - 흡입 캡슐 업계

경쟁 대시보드
- 경쟁 벤치마크
- 경쟁 포지셔닝
기업 개요
- AstraZeneca PLC
- GlaxoSmithKline plc
- Novartis International AG
- Cipla Limited
- Boehringer Ingelheim GmbH
- Merck &Co., Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Lupin Pharmaceuticals, Inc.
- UCB SA
- Hovione
- Dr. Reddy's Laboratories Ltd.
- Laboratorios Farmaceuticos Rovi, SA
- Vectura Group plc
- MannKind Corporation
- Catalent Pharma Solutions
- Pfizer Inc.
- Ferring Pharmaceuticals Inc.
- 기타

제12장 애널리스트의 전방위 전망

ksm 25.02.03

REPORT HIGHLIGHT

Inhalation Capsules Market size was valued at USD 831.90 Million in 2023, expanding at a CAGR of 6.50% from 2024 to 2032.

Inhalation capsules are specialized pharmaceutical capsules containing powdered medication intended for delivery directly into the lungs through inhalation. These capsules are used with inhalation devices and are designed to ensure the medication reaches the lungs efficiently. This method of drug delivery is particularly important for respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD), where localized treatment is crucial. The inhalation route allows for faster onset of action compared to oral medications, as it bypasses the digestive system, providing quicker relief. Additionally, it reduces the risk of systemic side effects since the drug is targeted directly to the lungs, improving the overall effectiveness and safety of treatment.

Inhalation Capsules Market- Market Dynamics

Rising prevalence of respiratory diseases to propel market demand

The rising prevalence of respiratory diseases is a significant factor driving the demand for inhalation capsules in the pharmaceutical market. Respiratory diseases, such as asthma, chronic obstructive pulmonary disease (COPD), and other lung-related conditions, have become more common due to factors like air pollution, smoking, aging populations, and genetic predispositions. These conditions often require long-term management, and inhalation therapies are considered one of the most effective treatment options, offering rapid and targeted relief.

As respiratory diseases grow in number, the need for more effective and convenient treatments also rises. Inhalation capsules, which provide a precise dosage and efficient drug delivery directly to the lungs, are becoming a preferred choice for patients with conditions like asthma and COPD. These capsules allow for better drug absorption in the lungs, improving therapeutic outcomes and reducing the frequency of systemic side effects seen with oral treatments. One statistic that highlights this trend is that, according to the World Health Organization (WHO), COPD is expected to become the third leading cause of death worldwide by 2030. This increase in COPD cases, alongside the growing asthma prevalence, fuels the demand for effective inhalation therapies. As a result, the inhalation capsule market is projected to experience significant growth as pharmaceutical companies continue to develop innovative solutions to address these widespread respiratory conditions.

Inhalation Capsules Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.50% over the forecast period (2024-2032)
Based on formulation segmentation, Powdered Inhalation Capsules was predicted to show maximum market share in the year 2023
Based on application segmentation, Asthma was the leading segment in 2023
On the basis of region, North America was the leading revenue generator in 2023

Inhalation Capsules Market- Segmentation Analysis:

The Global Inhalation Capsules Market is segmented on the basis of Formulation, Application, Release Mechanism and Region.

The market is divided into three categories based on formulation: powdered inhalation capsules, and liquid-filled capsules. The powdered inhalation capsules sector dominates the market. The powdered inhalation capsules sector dominates the market due to several key factors. First, they provide efficient drug delivery directly to the lungs, where they are most needed for conditions like asthma and COPD. The fine powder ensures deep lung penetration, maximizing the drug's effectiveness.

The market is divided into two categories based on application: asthma, chronic obstructive pulmonary disease, pulmonary infections, and pulmonary hypertension. Asthma dominates the market and is likely to maintain its dominance during the forecast period due to its high prevalence, environmental triggers, and ongoing treatment advancements. Over 260 million people worldwide suffer from asthma, making it one of the most common chronic respiratory diseases. This large patient population drives continuous demand for asthma treatments, including inhalation therapies

Inhalation Capsules Market- Geographical Insights

The inhalation capsules market is experiencing growth across various regions due to the increasing prevalence of respiratory diseases and the rising adoption of advanced drug delivery systems. North America holds a significant share, driven by a well-established healthcare infrastructure, high healthcare spending, and a large patient population with respiratory conditions like asthma and COPD. Europe also plays a key role, with a growing aging population and strong healthcare systems supporting the adoption of inhalation therapies. In Asia-Pacific, rapid market growth is expected, fueled by rising respiratory disease incidences, expanding healthcare infrastructure, and government initiatives aimed at improving healthcare access. Latin America is seeing increased demand due to rising smoking rates, urbanization, and air pollution, while the Middle East and Africa face a growing respiratory disease burden but have more limited access to advanced healthcare. However, ongoing healthcare improvements in these regions are expected to drive future market growth.

Inhalation Capsules Market- Competitive Landscape:

The inhalation capsules market is highly competitive, driven by the increasing demand for effective respiratory treatments and continuous advancements in drug delivery technologies. Companies are focusing on developing innovative inhalation products, particularly dry powder inhalers (DPIs), with improved formulations that offer better bioavailability and faster onset of action. Strategic partnerships and collaborations between pharmaceutical companies, research organizations, and healthcare providers are crucial in expanding market reach and enhancing product offerings. Additionally, ensuring regulatory compliance and obtaining approvals from health authorities across different regions is vital for market players to stay competitive and maintain product availability, further fueling the growth of the market.

Recent Developments:

In February 2024, Catalent announced the addition of potent capsule filling capabilities for inhaled dry powders at its Boston, MA facility. This expansion aims to meet the growing demand for complex drug delivery solutions in the pharmaceutical industry. The new capabilities will support clients developing inhalation therapies, enhancing Catalent's offerings in the field of biologics and advanced drug formulations.
In August 2023, Lupin launched its Tiotropium Dry Powder Inhaler in the United States for the treatment of COPD, expanding its respiratory portfolio with a cost-effective solution aimed at improving patient access to this critical therapy.
In June 2024, Verona Pharma announced the U.S. FDA approval of Ohtuvayre(TM) (ensifentrine), a novel treatment for chronic obstructive pulmonary disease (COPD), marking a significant milestone in the company's respiratory therapeutics pipeline. The approval is expected to enhance the management of COPD symptoms by combining both bronchodilator and anti-inflammatory properties in a single inhaled therapy, offering a new option for patients who are not adequately controlled with current treatments.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INHALATION CAPSULES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

AstraZeneca PLC
GlaxoSmithKline plc
Novartis International AG
Cipla Limited
Boehringer Ingelheim GmbH
Merck & Co., Inc.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Lupin Pharmaceuticals, Inc.
UCB S.A.
Hovione
Dr. Reddy's Laboratories Ltd.
Laboratorios Farmaceuticos Rovi, S.A.
Vectura Group plc
MannKind Corporation
Catalent Pharma Solutions
Pfizer Inc.
Ferring Pharmaceuticals Inc.
Others

GLOBAL INHALATION CAPSULES MARKET, BY FORMULATION TYPE- MARKET ANALYSIS, 2019 - 2032

Powdered Inhalation Capsules
Liquid-filled Capsules

GLOBAL INHALATION CAPSULES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Asthma
Chronic Obstructive Pulmonary Disease
Pulmonary Infections
Pulmonary Hypertension

GLOBAL INHALATION CAPSULES MARKET, BY RELEASE MECHANISM- MARKET ANALYSIS, 2019 - 2032

Immediate Release
Controlled Release

GLOBAL INHALATION CAPSULES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Inhalation Capsules Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Inhalation Capsules Market Snippet by Formulation
- 2.1.2. Inhalation Capsules Market Snippet by Application
- 2.1.3. Inhalation Capsules Market Snippet by Release Mechanism
- 2.1.4. Inhalation Capsules Market Snippet by Country
- 2.1.5. Inhalation Capsules Market Snippet by Region
2.2. Competitive Insights

3. Inhalation Capsules Key Market Trends

3.1. Inhalation Capsules Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Inhalation Capsules Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Inhalation Capsules Market Opportunities
3.4. Inhalation Capsules Market Future Trends

4. Inhalation Capsules Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Inhalation Capsules Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Inhalation Capsules Market Landscape

6.1. Inhalation Capsules Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Inhalation Capsules Market - By Formulation

7.1. Overview
- 7.1.1. Segment Share Analysis, By Formulation, 2023 & 2032 (%)
- 7.1.2. Powdered Inhalation Capsules
- 7.1.3. Liquid-filled Capsules

8. Inhalation Capsules Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 8.1.2. Asthma
- 8.1.3. Chronic Obstructive Pulmonary Disease
- 8.1.4. Pulmonary Infections
- 8.1.5. Pulmonary Hypertension

9. Inhalation Capsules Market - By Release Mechanism

9.1. Overview
- 9.1.1. Segment Share Analysis, By Release Mechanism, 2023 & 2032 (%)
- 9.1.2. Immediate Release
- 9.1.3. Controlled Release

10. Inhalation Capsules Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Inhalation Capsules Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Inhalation Capsules Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Inhalation Capsules Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Inhalation Capsules Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Inhalation Capsules Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Inhalation Capsules Industry

11.1. Competitive Dashboard
- 11.1.1. Competitive Benchmarking
- 11.1.2. Competitive Positioning
11.2. Company Profiles
- 11.2.1. AstraZeneca PLC
- 11.2.2. GlaxoSmithKline plc
- 11.2.3. Novartis International AG
- 11.2.4. Cipla Limited
- 11.2.5. Boehringer Ingelheim GmbH
- 11.2.6. Merck & Co., Inc.
- 11.2.7. Sun Pharmaceutical Industries Ltd.
- 11.2.8. Teva Pharmaceutical Industries Ltd.
- 11.2.9. Lupin Pharmaceuticals, Inc.
- 11.2.10. UCB S.A.
- 11.2.11. Hovione
- 11.2.12. Dr. Reddy's Laboratories Ltd.
- 11.2.13. Laboratorios Farmaceuticos Rovi, S.A.
- 11.2.14. Vectura Group plc
- 11.2.15. MannKind Corporation
- 11.2.16. Catalent Pharma Solutions
- 11.2.17. Pfizer Inc.
- 11.2.18. Ferring Pharmaceuticals Inc.
- 11.2.19. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us